Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth

Hypertension

Volumn 27, Issue 4, 1996, Pages 885-892

  Gómez Garre, Dulcenombre ^a   Ruiz Ortega, Marta ^a   Ortego, Mónica ^a   Largo, Raquel ^a   López Armada, Maria José ^a   Plaza, Juan J ^a   González, Eva ^a   Egido, Jesús ^a,b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b Institute Jimenez Dias   (Spain)

Author keywords

angiotensin II; angiotensin converting enzyme inhibitors; endothelin; matrix proteins; mesangial cells; protein kinases; transforming growth factors

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; CAPTOPRIL; COLLAGEN TYPE 4; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; FIBRONECTIN; LOSARTAN; MESSENGER RNA; NEUTRALIZING ANTIBODY; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; QUINAPRIL; STAUROSPORINE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CELL GROWTH; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DOSE RESPONSE; GENE EXPRESSION; GLOMERULOSCLEROSIS; MESANGIUM CELL; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; VASOCONSTRICTION;

EID: 0029963298     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.27.4.885     Document Type: Article

References (44)

1. Kashgarian M, Sterzel RB. The pathobiology of the mesangium . Kidney Int. 1992;41:524-529.
2. Simonson MS. Endothelins: multifunctional renal peptides. Physiol Rev. 1993;73:375-411.
3. Ichikawa I, Harris RC. Angiotensin actions in the kidney: renewed insight into the old hormone. Kidney Int. 1991;40:583-596.
4. Rupprecht HD, Dann P, Sukhatme VP, Sterzel RB, Coleman DL. Effect of vasoactive agents on induction of Egr-1 in rat mesangial cells: correlation with mitogenicity. Am J Physiol. 1992;263:F623-F636.
5. Orisio S, Benigni A, Bruzzi I, Corna D, Perieo N, Zoja C, Beantti L, Remuzzi G. Renal endothelin gene expression is increased in remnant kidney and correlates with disease progression. Kidney Int. 1993;43:354-358.
6. B receptor antagonist improves proteinuria and glomerular lesions in a normotensive rat model of immune complex nephritis. J Am Soc Nephrol. 1995;6:866. Abstract.
7. Benigni A, Zoja C, Corna D, Orisio S, Longaretti L, Bertani T, Remuzzi G. A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression. Kidney Int. 1993;44:440-444.
8. Nakamura T, Ebihara I, Tomino Y, Koide H. Effect of a specific endothelin A receptor antagonist on murine lupus nephritis. Kidney Int. 1995;47:481-489.
9. Egido J. Vasoactive hormones and renal sclerosis: Nephrology Forum. Kidney Int. 1996;49:578-597.
10. Johnson RL, Alpes CE, Yoshimura A, Lombardi D, Pritzl P, Floege J, Schwartz SM. Renal injury from angiotensin II-mediated hypertension. Hypertension. 1992;19:464-474.
11. Chua BHL, Chua CC, Diglio CA, Siu BB. Regulation of endothelin-I mRNA by angiotensin II in rat heart endothelial cells. Biochim Biophys Acta. 1993;1178:201-206.
12. Kohno M, Horio T, Ikeda M, Yokokawa K, Fukui T, Yasunari K, Kurihara N, Takeda T. Angiotensin II stimulates endothelin-1 secretion in cultured rat mesangial cells. Kidney Int. 1992;42:860-866.
13. Bakris GL, Re RN. Endothelin modulates angiotensin II-induced mitogenesis of human mesangial cells. Am J Physiol. 1993;264:F937-F942.
14. Kawaguchi H, Sawa H, Yasuda H. Endothelin stimulates angiotensin I to angiotensin II conversion in cultured pulmonary artery endothelial cells. J Mol Cell Cardiol. 1991;22:839-842.
15. Gómez-Guerrero C, López-Armada MJ, Gonzalez E. Egido J. Soluble IgA and IgG aggregated are catabolizcd by cultured rat mesangial cells and induce TNF-α and IL-6, and proliferation. J Immunol. 1994;153:5247-5255.
16. Mené P, Simonson MS. Dunn MJ. Physiology of the mesangial cells. Physiol Rev. 1989;69:1347-1424.
17. Chomezynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
18. Ruiz-Ortega M, González S, Seron D, Condom E, Bustos C, Largo R, González E, Ortiz A, Egido J. ACE inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis. Kidney Int. 1995;48:1778-1791.
19. Simonson MS, Culp LA, Dunn MJ. Rat mesangial cell-matrix interactions in culture. Exp Cell Res. 1989;184:484-489.
20. A. J Am Soc Nephrol. 1994;5:1074-1080.
21. Chanzel D, Czekalski S, Pham P, Ardaillou R. Characterization of angiotensin II receptor subtypes in human glomeruli and mesangial cells. Am J Physiol. 1992;262:F432-F441.
22. 1 receptors. Kidney Int. 1994;45:177-184.
23. Gibbons GH, Pratt RE, Dzau VJ. Vascular smooth muscle cell hypertrophy vs hyperplasia. Autocrine transforming growth factor-β1 expression determines growth response to angiotensin II. J Clin Invest. 1992;90:456-461.
24. Kagami S, Border WA, Miller DE, Noble N. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest. 1994;93:2431-2437.
25. Border WA, Ruoslahti E. Transforming growth factor β in disease: the dark side of tissue repair. J Clin Invest. 1992;90:1-7.
26. Dzau VJ, Ingelfinger JR. Molecular biology and pathophysiology of the intrarenal renin and angiotensin system. J Hypertens. 1989;7:S3-S8.
27. Saltis J, Agrotis A, Bobik A. Transforming growth factor-beta 1 enhances the proliferative effects of epidermal growth factor on vascular smooth muscle from the spontaneously hypertensive rat. J Hypertens. 1991;9:S184-S185.
28. Kaneto H, Morrissey J, Klahr S. Increased expression of TGF-β1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation. Kidney Int. 1993;44:313-321.
29. Pimentel JL, Martínez-Maldonado M, Wilcox JN, Wang S, Luo C. Regulation of renin-angiotensin system in unilateral ureteral obstruction. Kidney Int. 1993;44:390-400.
30. Kaneto H, Morrissey J, McCracken R, Reyes A, Klahr S. Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney. Kidney Int. 1994;45:1637-1647.
31. Anderson SF, Jung F, Ingelfinger JR. Renal renin-angiotensin system in diabetes: functional, inmunohistochemical, and molecular biological correlations. Am J Physiol. 1993;265:F477-F486.
32. Nakamura T, Ebihara I, Fukui M, Osada S, Tomino Y, Masaki T, Goto K, Furuichi Y, Koide H. Renal expression of mRNAs for endothelin-1, endothelin-3 and endothelin receptors in NZB/W F1 mice. Renal Physiol Biochem. 1993;16:233-244.
33. Naftilan AJ, Pratt RE, Dzau JV. Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1419-1424.
34. Curran T, Franza BR. Fos and jun: the AP-1 connection. Cell. 1988;55:395-397.
35. Kim S-J, Denhez F, Kim KY, Holt JT, Sporn MB, Roberts AB. Activation of the second promoter of the transforming growth factor beta-1 gene by transforming growth factor beta-1 and phorbol ester occurs through the same target sequences. J Biol Chem. 1989;264:19373-19378.
36. Studer RK, Negrete H, Craven PA, DeRubertis FR. Protein kinase C signals thromboxane induced increases in fibronectin synthesis and TGF-β bioactivity in mesangial cells. Kidney Int. 1995;48:422-430.
37. Ito H, Hirata Y, Adachi S, Tanaka M, Tsujimo M, Koike A, Nogami A, Murumo F, Hiroe M. Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J Clin Invest. 1993;92:398-403.
38. Webb ML, Dickinson KE, Delaney CL, Liu ECK, Serafino R, Cohen RB, Monshizadengan H, Moreland S. The endothelin receptor antagonist, BQ 123, inhibits angiotensin II-induced contractions in rabbit aorta. Biochem Biophys Res Commun. 1992;185:887-892.
39. Bakris GL, Bhandaru S, Akerstrom V, Re RN. ACE inhibitor-mediated attenuation of mesangial cell growth: a role for endothelin. Am J Hypertens. 1994;7:583-590.
40. Neyses L, Nouskas J, Oberdorf S, Vetter H. Action of an ACE inhibitor on myocardial early growth responses. J Cardiovasc Pharmacol. 1992;20:S12-S14.
41. 2+ in glomerular mesangial cells. Kidney Int. 1994;46:696-702.
42. Chan DP, Clavell A, Keiser J, Burnett JC Jr. Effects of renin-angiotensin system in mediating endothelin-induced renal vasoconstriction: therapeutic implications. J Hypertens. 1994:12(suppl 4):S43-S49.
43. Largo R, Liu XH, Gómez-Garre D, Alonso J, Ruiz-Ortega M, Egido J. The ACE inhibitor quinapril suppresses endothelin-1 gene expression in the kidney of uninephrectomized spontaneously hypertensive rats (SHR). J Am Soc Nephrol. 1995;6:626. Abstract.
44. Fukui M, Nakamura T, Ebihara I. Effects of enalapril on endothelin-1 and growth factor gene expression in diabetic rat glomeruli. J. Lab Clin Med. 1994;123:743-748.